-
-
-
-
-
-
-
Iovance Biotherapeutics (IOVA) Misses Q4 EPS by 1c
-
-
-
-
-
-
-
Iovance Biotherapeutics Reports Financial ResultsĀ and Corporate Updates for Second Quarter and First Half 2025
-
-
-
-
-
-
-
IOVA NOTIFICATION: Iovance Biotherapeutics Investors that Lost Money on their Investment are Notified to Contact BFA Law by July 14 Class Action Deadline
-
-
-
-
-
-
-
Faruqi & Faruqi Reminds Iovance Biotherapeutics of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 14, 2025 - IOVA
-
-
-
-
-
-
-
IOVA Investors Have the Opportunity to Lead the Iovance Biotherapeutics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
-
-
-
-
-
-
-
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
-
-
-
-
-
-
-
IOVA SECURITIES ALERT: Iovance Biotherapeutics Investors are Notified to Contact BFA Law before the Upcoming July 14 Class Action Deadline
-
1,217,581 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

